Operating Lease, Payments of Evelo Biosciences, Inc. from 31 Mar 2020 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Evelo Biosciences, Inc. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Mar 2020 to 31 Mar 2023.
  • Evelo Biosciences, Inc. Operating Lease, Payments for the quarter ending 31 Mar 2023 was $800,000, unchanged year-over-year.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2022 was $3,100,000, a 3.3% increase from 2021.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2021 was $3,000,000, a 10% decline from 2020.
Source SEC data
View on sec.gov
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Evelo Biosciences, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $800,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $800,000 +$62,000 +8.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $738,000 -$99,000 -12% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q2 2020 $1,634,000 01 Apr 2020 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $837,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2020 2020 Q1

Evelo Biosciences, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $3,100,000 +$100,000 +3.3% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $3,000,000 -$334,000 -10% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $3,334,000 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.